bausch health companies inc glp-1 receptor agonist medications The Power of Discovery: Agonists Evolution of GLP‐1 Receptor Agonists
Description
May 18, 2026/Heart, Vascular and Thoracic/Heart Failure & Transplant GLP-1 RAs Show Survival and Cardiovascular Benefits in Patients With HFrEF and Diabetes Large retrospective analysis may prompt prospective studies April 30, 2026/Ob/Gyn & Womens Health/Maternal-Fetal Medicine Preconception GLP-1 Use Not Linked to Higher Pregnancy Risk Data point to potential for targeted preconception planning April 10, 2026/Heart, Vascular and Thoracic/Vascular Medicine New Data Suggest GLP-1 Receptor Agonists Slow Abdominal Aortic Aneurysm Progression Robust signal from observational study raises prospect of a long-sought medical therapy March 30, 2026/Heart, Vascular and Thoracic/Preventive Cardiology Dual-Agonist Incretin Therapy Outshines GLP-1 Agonist in Broad Cardiorenal Outcomes Post hoc analysis of SURPASS-CVOT trial has implications for future cardiovascular outcome trials Advertisement Cleveland Clinic is a non-profit academic medical center
Efficacy and safety of liraglutide and semaglutide on weight loss in people with obesity or overweight: A systematic review
Tahrani AA, Morton J
No video call required
Take the Next Step Toward Your Weight Loss Goals Are you ready to take control of your weight loss and management
Physical activity: Regular aerobic exercise (such as brisk walking) and daily movement help maintain weight loss and support overall health
